Survival and prognostic factors for patients with advanced hepatocellular carcinoma after stereotactic ablative radiotherapy

• Cheng-Hsiang Lo,

  Affiliation Department of Radiation Oncology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan

  ⨯
• Jen-Fu Yang,

  Affiliation Department of Radiation Oncology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan

  ⨯
• Ming-Yueh Liu,

  Affiliation Department of Radiation Oncology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan

  ⨯
• Yee-Min Jen,

  Affiliations Department of Radiation Oncology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, Department of Radiation Oncology, Yee Ren Hospital, Taoyuan, Taiwan

  ⨯
• Chun-Shu Lin,

  Affiliation Department of Radiation Oncology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan

  ⨯
• Hsing-Lung Chao,

  Affiliation Department of Radiation Oncology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan

  ⨯
• Wen-Yen Huang

  * E-mail: hwyyi@yahoo.com.tw

  Affiliations Department of Radiation Oncology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan, Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan

  http://orcid.org/0000-0002-8354-3320

  ⨯